Showing results (191-200 of 299) with videos related to
Sort By:
Pageof 30
Deutsche Medizinische Wochenschrift (1946)|December 30, 1977
[Combined doxorubicin and bleomycin treatment of metastasising thyroid carcinoma: results in 21 patients (author's transl)]G Benker, K Hackenberg, H G Hoff, et al.Annals of Hematology|November 1, 1992
Cytotoxicity of adriamycin, idarubicin, and vincristine in acute myeloid leukemia: chemosensitization by verapamil in relation to P-glycoprotein expressionM R Müller, K Lennartz, C Boogen, et al.Annals of Hematology|September 2, 2004
Hemolytic uremic syndrome following prolonged gemcitabine therapy: report of four cases from a single institutionS Müller, P Schütt, P Bojko, et al.Annals of Hematology|September 1, 1992
Relation between leukocyte counts and cortisol secretion in CML patients undergoing combined TNF alpha/IFN alpha therapyM Nagel-Hiemke, C Hiemke, G Kummer, et al.Gene|November 15, 2001
Energy transfer between fluorescent proteins using a co-expression system in Mycobacterium smegmatisI Kaps, S Ehrt, S Seeber, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 1, 1993
The neu-oncogene product in serum and tissue of patients with breast carcinomaR Kath, K Höffken, C Otte, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1995
Low specificity of cytokeratin 19 reverse transcriptase-polymerase chain reaction analyses for detection of hematogenous lung cancer disseminationM Krismann, B Todt, J Schröder, et al.Deutsche Medizinische Wochenschrift (1946)|June 1, 1979
[Combined chemotherapy and radiotherapy of localized and metastasizing Ewing's sarcoma (author's transl)]S Seeber, E Siemers, K Höffken, et al.Leukemia & Lymphoma|June 1, 1997
Recurrence of Hodgkin's disease after 10 or more years: late relapse or de-novo malignancy due to HLA-DPB1*0301-linked susceptibility?R Siebert, A Fosså, W Kaiser, et al.Obstetrics and Gynecology International|February 20, 2010
Hypoxia-inducible factor-1 as a therapeutic target in endometrial cancer managementLaura M S Seeber, Ronald P Zweemer, René H M Verheijen, et al.Pageof 30